Sara Brenner, a preventive medicine and public health physician at the US FDA who served in the first Trump administration, has been named the agency’s acting commissioner.
The Trump administration has tapped a former HHS official to run the US FDA while Martin Makary, the president’s nominee, awaits Senate confirmation. Most recently, Brenner served as the chief medical officer for in vitro diagnostics and associate director for medical affairs at the agency’s device center.
Prior to her role as the chief medical officer for IVDs at CDRH, Brenner worked in data analytics and on...
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
The ceramic device, designed to reduce complications, will be exclusively distributed by Zimmer Biomet and initially available in 30 hospitals, with broader European access expected by 2026.
Medtronic beat first-quarter revenue and EPS estimates, raised guidance, and added two board members and special committees as Elliott takes a stake.
Entrepreneurialism is in the blood of Israel’s medtech innovators, but in a changing medtech world, the local ecosystem must address funding gaps and manufacturing and infrastructure needs. So says Ruti Alon, experienced Israeli medtech leader, investor and co-chair of the Biomed Israel conference.
Apreo Health CEO Karun Naga talks to Medtech Insight about the company’s intentions for its Series B funding. The Breathe-3 clinical trial and early commercialization activities, involving physician education, are top priorities.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Exact Sciences has entered into an exclusive licensing agreement with Freenome, stipulating clinical benchmarks and a first-line rating in the USPSTF guidelines. Medtech Insight interviewed screening CMO Paul Limburg about CRC screening and Exact’s strategy on liquid biopsy.
